Addison Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68K | Sell |
7
-9
| -56% | -$4.73K | ﹤0.01% | 726 |
|
|
2025
Q1 | $10.1K | Sell |
16
-8
| -33% | -$5.08K | ﹤0.01% | 580 |
|
|
2024
Q4 | $17.1K | Buy |
24
+10
| +71% | +$7.12K | ﹤0.01% | 521 |
|
|
2024
Q3 | $14.7K | Sell |
14
-2
| -13% | -$2.1K | ﹤0.01% | 547 |
|
|
2024
Q2 | $16.8K | Sell |
16
-5
| -24% | -$5.26K | 0.01% | 503 |
|
|
2024
Q1 | $20.2K | Sell |
21
-17
| -45% | -$16.4K | 0.01% | 457 |
|
|
2023
Q4 | $33.4K | Hold |
38
| – | – | 0.01% | 399 |
|
|
2023
Q3 | $31.3K | Sell |
38
-8
| -17% | -$6.58K | 0.01% | 374 |
|
|
2023
Q2 | $33.1K | Hold |
46
| – | – | 0.02% | 365 |
|
|
2023
Q1 | $37.8K | Sell |
46
-2
| -4% | -$1.64K | 0.02% | 330 |
|
|
2022
Q4 | $34.6K | Hold |
48
| – | – | 0.02% | 320 |
|
|
2022
Q3 | $33K | Hold |
48
| – | – | 0.02% | 301 |
|
|
2022
Q2 | $28K | Hold |
48
| – | – | 0.02% | 328 |
|
|
2022
Q1 | $34K | Buy |
48
+33
| +220% | +$23.4K | 0.02% | 337 |
|
|
2021
Q4 | $9K | Buy |
15
+13
| +650% | +$7.8K | 0.01% | 418 |
|
|
2021
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 425 |
|
|
2021
Q2 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 391 |
|